Stem Cell-Derived Extracellular Vesicles for Cancer Therapy and Tissue Engineering Applications
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Chung-Sung | - |
dc.contributor.author | Lee, Min | - |
dc.contributor.author | Na, Kun | - |
dc.contributor.author | Hwang, Hee Sook | - |
dc.date.accessioned | 2024-01-26T05:31:26Z | - |
dc.date.available | 2024-01-26T05:31:26Z | - |
dc.date.issued | 2023-10 | - |
dc.identifier.issn | 1543-8384 | - |
dc.identifier.issn | 1543-8392 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/25887 | - |
dc.description.abstract | Recently, stem cells and their secretomes have attracted great attention in biomedical applications, particularly extracellular vesicles (EVs). EVs are secretomes of cells for cell-to-cell communication. They play a role as intercellular messengers as they carry proteins, nucleic acids, lipids, and therapeutic agents. They have also been utilized as drug-delivery vehicles due to their biocompatibility, low immunogenicity, stability, targetability, and engineerable properties. The therapeutic potential of EVs can be further enhanced by surface engineering and modification using functional molecules such as aptamers, peptides, and antibodies. As a consequence, EVs hold great promise as effective delivery vehicles for enhancing treatment efficacy while avoiding side effects. Among various cell types that secrete EVs, stem cells are ideal sources of EVs because stem cells have unique properties such as self-renewal and regenerative potential for transplantation into damaged tissues that can facilitate their regeneration. However, challenges such as immune rejection and ethical considerations remain significant hurdles. Stem cell-derived EVs have been extensively explored as a cell-free approach that bypasses many challenges associated with cell-based therapy in cancer therapy and tissue regeneration. In this review, we summarize and discuss the current knowledge of various types of stem cells as a source of EVs, their engineering, and applications of EVs, focusing on cancer therapy and tissue engineering. | - |
dc.format.extent | 34 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.title | Stem Cell-Derived Extracellular Vesicles for Cancer Therapy and Tissue Engineering Applications | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1021/acs.molpharmaceut.3c00376 | - |
dc.identifier.scopusid | 2-s2.0-85176496879 | - |
dc.identifier.wosid | 001100102600001 | - |
dc.identifier.bibliographicCitation | MOLECULAR PHARMACEUTICS, v.20, no.11, pp 5278 - 5311 | - |
dc.citation.title | MOLECULAR PHARMACEUTICS | - |
dc.citation.volume | 20 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 5278 | - |
dc.citation.endPage | 5311 | - |
dc.type.docType | Review | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | MESENCHYMAL STROMAL CELLS | - |
dc.subject.keywordPlus | DRUG-DELIVERY SYSTEM | - |
dc.subject.keywordPlus | BONE-MARROW | - |
dc.subject.keywordPlus | POLYMERIC NANOPARTICLES | - |
dc.subject.keywordPlus | INTERNATIONAL-SOCIETY | - |
dc.subject.keywordPlus | LOADED EXOSOMES | - |
dc.subject.keywordPlus | ADIPOSE | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | DOXORUBICIN | - |
dc.subject.keywordPlus | REPAIR | - |
dc.subject.keywordAuthor | Stem cells | - |
dc.subject.keywordAuthor | extracellular vesicles | - |
dc.subject.keywordAuthor | cell-freetherapy | - |
dc.subject.keywordAuthor | cancer treatment | - |
dc.subject.keywordAuthor | tissue engineering | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.